Older Adults Reporting More Diabetes Mellitus Care Have Greater 9‐Year Survival by Han, Benjamin H. et al.
Older Adults Reporting More Diabetes Mellitus Care Have
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Benjamin H. Han, MD, MPH,* Caroline S. Blaum, MD, MS,* Rosie E. Ferris, MPH,*
Lillian C. Min, MD, MSHS,†‡ and Pearl G. Lee, MD†‡
OBJECTIVES: To determine whether receiving more rec-
ommended diabetes mellitus (DM) care processes (tests
and screenings) would translate into better 9-year survival
for middle-aged and older adults.
DESIGN: Longitudinal mortality analysis using the Health
and Retirement Study Diabetes Mailout Survey.
SETTING: Health and Retirement Study (HRS).
PARTICIPANTS: Individuals aged 51 and older
(n = 1,879; mean age 68.8  8.7, 26.5% aged ≥75) with
self-reported DM who completed the Diabetes Mailout
Survey and the core 2002 HRS survey.
MEASUREMENTS: A composite measure of five self-
reported diabetes mellitus care process measures were
dichotomized as greater (3–5 processes) versus fewer (0–2
processes) care processes provided. Cox proportional haz-
ards models were used to test relationships between
reported measures and mortality, controlling for sociode-
mographic characteristics, function, comorbidities, geri-
atric conditions, and insulin use.
RESULTS: Prevalence of self-reported care processes was
80.1% for glycosylated hemoglobin test, 75.9% for urine
test, 67.5% for eye examination, 67.7% for aspirin coun-
seling, and 48.2% for diabetes education. In 9 years,
32.1% respondents died. Greater care correlated with 24%
lower risk of dying (adjusted hazard ratio = 0.76, 95%
confidence interval = 0.64–0.91) at 9-year follow up. When
respondents were age-stratified (≥75 vs <75) longer survival
was statistically significant only in the older age group.
CONCLUSION: Although it is not possible to account
for differences in adherence to care that may also affect
survival, this study demonstrates that monitoring of and
counseling about types of DM care processes are associ-
ated with long-term survival benefit even in individuals
aged 75 and older with DM. J Am Geriatr Soc 63:2455–
2462, 2015.
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Diabetes mellitus (DM) disproportionately affects olderadults. In 2010, 27% of U.S. residents aged 65 and
older had DM, versus 8% of the overall U.S. population.1
Evidence suggests that cardiovascular complications of
DM can be reduced or delayed with optimal DM care,2
but care of individuals with DM aimed at preventing com-
plications has been inconsistent and suboptimal.3,4 In addi-
tion, the benefits of current standard DM care remains
inconclusive for older adults, particularly after age 75.
Healthcare performance measures can be grouped
broadly into two types: those based on recommended care
processes (whether or not providers performed care, e.g.,
measuring serum glycosylated hemoglobin (HbA1c and
lipids, screening for retinopathy, diet counseling, examin-
ing feet) and intermediate care outcomes (whether targets
were met for glycosylated HbA1c, blood pressure, or lipid
levels). Performance of DM care processes and care out-
comes has improved nationally over the past decade.5–8
Recent research suggests that overly aggressive goals for
intermediate outcomes in older adults may result in unin-
tended harms (e.g., hypoglycemia) that outweigh long-term
cardiovascular benefits,9–11 but whether providing care
processes is associated with similar harm in very old adults
has not been well studied, and it is not known which older
adults with comorbidities might benefit from risk factor
control.12 No studies have directly addressed whether
delivery of more recommended DM care processes is asso-
ciated with longer survival.
This study of DM care processes examined middle-
aged to older participants from the nationally representa-
tive Health and Retirement Study (HRS) and tested
whether those who reported receiving more recommended
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DM care processes had longer long-term survival than
those who reported receiving fewer and whether the asso-
ciation differed between those younger than 75 and those
aged 75 and older.
METHODS
This was a 9-year follow-up study using the 2003 Diabetes
Mailout Survey data, a supplemental survey to the 2002
core Health and Retirement Study (HRS). The HRS13 is a
biennial health interview of community-dwelling older
adults living in the United States. The HRS is sponsored
by the National Institute on Aging and conducted by the
Institute for Social Research at the University of Michigan.
Respondents are surveyed every 2 years in person or by
telephone even if living in a residential facility. If an indi-
vidual is unable to complete the survey, a proxy completes
it for him or her. To ensure the representativeness of the
population surveyed, African-American and Hispanic
adults are oversampled. In contrast to most care processes
studies using health system data, the HRS Diabetes Mail-
out Survey is independent of participants’ health insurance
status.
Data from the 1,879 respondents aged 51 and older
with self-reported DM who completed the Diabetes Mail-
out Survey and the core 2002 HRS survey were analyzed.
The HRS includes complete linkage with mortality data in
the National Death Index on all respondents through the
end of 2010, which is included in the 2013 Cross-Wave
Tracker File. The HRS survival data are therefore com-
pletely ascertained (no loss to follow-up).
The Behavioral Sciences Committee institutional
review board at the University of Michigan approved the
HRS. The New York University School of Medicines insti-
tutional review board exempted the current study from
review. HRS data contain no unique identifiers and are
publicly available.
Outcome Measure
The outcome was time to death for each respondent, cal-
culated as the time from the date of participation in the
2002 core interview to the date of death. Because the anal-
yses included mortality data through December 31, 2010,
participants were censored if they were still alive on Jan-
uary 1, 2011. None of the censorings were due to dropout
because there are complete data for survival outcomes in
the HRS.
Process of Care Measures
In the Diabetes Mailout Survey, each respondent was
asked whether they had received any of six DM care pro-
cesses in the past year: a glycosylated hemoglobin (HbA1c)
test, a urine test, a DM eye examination, aspirin counsel-
ing, DM education, and lipid profile test.
Four of the measures (HbA1c testing, urine test, eye
examination, DM education) were part of the initial Dia-
betes Quality Improvement Program (DQIP) measure set
in the late 1990s3 and recommended as part of the 2015
American Diabetes Association (ADA) standards of medi-
cal care guidelines for diabetes mellitus,2 endorsed by the
National Quality Forum (NQF).14 Although now contro-
versial, aspirin use counseling was widely recommended in
2003,3,4,6 including by the ADA for primary cardiovascu-
lar prevention for adults with DM aged 30 and older.15
Although self-report of lipid profile was part of the
Diabetes Mailout Survey, this measure was not included in
the current analysis because of missing data in 10.0% of
the study population (vs <5% of for the other five mea-
sures). Other DQIP, NQF, and ADA measures such as
annual foot examination and vaccinations2,3,14 were not
asked about in the Diabetes Mailout Survey.
If the respondent answered that they received the DM
care process, that item was counted as one care process
provided. Although the number of missing responses was
low (<5% for any single care process question), to reduce
bias and produce the most-conservative results, all missing
responses were presumed as not provided for that particu-
lar care process (contributed a count of 0 toward the total
care process score). Therefore, each respondent was con-
sidered as being eligible for five total care processes for
this analysis. The provided care processes out of a total
five possible were summed, and then the respondents were
classified into two groups according to median total count:
those who received fewer (0–2 care processes) versus those
who received more recommended DM care processes (3–5
care processes).
Covariables
Baseline sociodemographic and health characteristics of
the respondents were assessed according to their answers
to the HRS 2003 Diabetes Mailout Survey and 2002 core
interview (Table 1). Sociodemographic characteristics
included age, race (white vs all others), sex, education
(<high school vs ≥high school), marriage status (single vs
married), and net worth (<$50,000 vs ≥$50,000). Func-
tional limitations were measured according to self-reported
number of activity of daily living (ADL; bathing, walking,
dressing, eating, transferring, toileting) and instrumental
activity of daily living (IADL; meal preparation, shopping
for groceries, managing medications, making telephone
calls, managing finances) limitations. Participants who had
difficulty with one or more ADLs or IADLs were defined
as having functional limitations. Total Illness Burden Index
(TIBI), a composite score (range 0–100) based on self-
reported symptoms and DM-related complications devel-
oped for the HRS, was used to measure DM severity and
general medical comorbidity.16–18 The Diabetes Mailout
Survey captured insulin use. Five geriatric conditions (as
dichotomous variables) were asked about in the core inter-
view: one or more injurious falls requiring medical care in
the past 2 years, urinary incontinence during the past
12 months, pain that is troublesome, poor or fair vision,
and poor or fair hearing. The sixth geriatric condition,
cognitive impairment, was measured using the modified
Telephone Interview for Cognition Survey (TICS-m).
Respondents with scores of 11 points or lower on the
27-item TICS-m, a cutoff score that identifies mild through
advanced stages of cognitive impairment, were determined
to have cognitive impairment.19 TICS-m includes multiple
domains of immediate and delayed recall, working mem-
ory and mental processing speed. The presence of each of
2456 HAN ET AL. DECEMBER 2015–VOL. 63, NO. 12 JAGS
the six geriatric condition variables was counted for each
respondent, resulting in a score representing each respon-
dent’s burden of geriatric conditions.
Statistical Analyses
All analyses were performed using Stata version 13 (Stata
Corp., College Station, TX). Standard descriptive statistical
techniques were used to determine the prevalence of pro-
cess measures and sociodemographic and health covariates
in the study sample and differences in these characteristics
between respondents with and without missing informa-
tion for each process-of-care measure variable. Visual
inspection of unadjusted Kaplan-Meier survivor curves
was used to confirm that the proportional hazard assump-
tion was satisfied over the 9 years of follow-up. The sur-
vival analysis was performed using a Cox proportional
hazards model comparing respondents provided with more
recommended care (3–5 care processes) with those pro-
vided with less recommended care (0–2 care processes),
with time until death as the dependent variable. Covariates
(age, sex, education, marriage status, net worth, functional
limitations, TIBI, insulin use, geriatric conditions) were
added in separately to assess confounding between care
process scores and time until death. Only covariates with
P < .10 in the univariate analyses between the two groups
were selected for inclusion in subsequent multivariable
modeling.
Table 2 shows the adjusted models and covariates
used in the analysis. Sensitivity analyses were performed
using the total care process scores as a continuous variable
rather than a dichotomous grouping in the multivariable
model. Whether the results were sensitive to a higher cut-
off was also tested using differently defined higher- and
lower-scoring groups (0–3 vs 4–5 care processes provided).
Lastly, a separate survival analysis was performed on the
entire sample stratified according to age (<75 vs ≥75).
RESULTS
Table 1 shows the demographic characteristics and health
status of the two groups of respondents stratified according
Table 1. Characteristics of Respondents According to Number of Process-of-Care Measures
Characteristic
All,
N = 1,879
0–2 Process-of-Care
Measures, n = 493
3–5 Process-of-Care
Measures, n = 1,386
P-Value: 0–2 Measures
vs 3–5 Measures
Age, meanSD 68.8  8.7 69.2  9.3 68.7  8.4 .03
51–64 646 (34.4) 177 (35.9) 469 (33.8)
65–74 735 (39.1) 169 (34.3) 566 (40.8)
≥ 75 498 (26.5) 147 (29.8) 351 (25.4)
Female, n (%) 984 (52.4) 277 (56.2) 707 (51.0)
Race, n (%)
White 1,288 (68.5) 322 (65.3) 966 (69.7) .5
Black 367 (19.5) 97 (19.7) 270 (19.5)
Hispanic 201 (10.7) 64 (13.0) 137 (9.9)
Other 23 (1.2) 10 (2.0) 13 (0.9)
Education, n (%)
<12th grade 659 (35.1) 211 (42.8) 448 (32.3) <.001
12th grade 621 (33.1) 150 (30.4) 471 (34.0)
>12th grade 595 (31.7) 131 (26.6) 464 (33.5)
Married, n (%) 1,251 (66.6) 302 (61.3) 949 (68.5) .004
Net worth, $, n (%)
<$50,000 601 (32.0) 195 (39.6) 406 (29.3) <.001
$50,000–534,999 1,044 (55.6) 248 (50.3) 796 (57.4)
≥$535,000 234 (12.5) 50 (10.1) 184 (13.3)
Number of activity of daily living difficulties, n (%)
0 1,413 (75.2) 359 (72.8) 1,054 (76.1) .09
1–3 389 (20.7) 106 (21.5) 283 (20.4)
4–6 77 (4.1) 28 (5.7) 49 (3.5)
Number of instrumental activity of daily living difficulties, n (%)
0 1,508 (80.3) 79.7% (n = 393) 1,115 (80.5) .07
1–2 251 (13.4) 59 (12.0) 192 (13.9)
3–5 118 (6.3) 41 (8.3) 77 (5.6)
Total Illness Burden Index, meanSD 36.0  18.9 34.1  18.5 36.7  19.0 .009
Geriatric conditions, n (%) .02
Injurious falls 117 (6.2) 30 (6.1) 87 (6.3) .88
Cognitive impairment 525 (27.9) 170 (34.5) 355 (25.6) <.001
Pain 687 (36.6) 171 (34.7) 516 (37.2) .33
Urinary incontinence 399 (21.2) 106 (21.5) 293 (21.1) .85
Hearing impairment 462 (24.6) 122 (24.8) 340 (24.5) .89
Visual impairment 519 (27.6) 166 (33.7) 353 (25.5) <.001
Insulin use, n (%) 411 (21.9) 77 (15.6) 334 (24.1) <.001
Alive in 2010 1,275 (67.9) 317 (64.3) 958 (69.1) .05
SD = standard deviation.
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to high and low care process scores. At baseline, the mean
age was 68.8  8.7, 52.4% were female, 68.5% were
white, and 21.9% were taking insulin. The prevalence of
self-reported process of care measures were 80.1% for
HbA1c test, 75.9% for urine test, 67.5% for eye examina-
tion, 67.7% for aspirin counseling, and 48.2% for DM edu-
cation. Of the 1,879 participants, 73.8% reported receiving
three to five process measures.
Those reported receiving more care processes (3–5 care
processes) were more likely to be younger (68.7  8.4 vs
69.2  9.3, P = .03), be male (49.0% vs 43.8%, P = .05),
be married (68.5% vs 61.3%, P = .004, have graduated
from high school (67.5% vs 57.0%, P ≤ .001), have higher
net worth (≥$50,000: 70.7% vs 60.4%, P ≤ .001), and use
insulin (24.1% vs 15.6%, P ≤ .001) and less likely to be
cognitively (25.6% vs 34.5%, P ≤ .001) or visually (25.5%
vs 33.7%, P ≤ .001) impaired. Those with more care pro-
cesses also had fewer of the six geriatric conditions (mean
1.40, 95% confidence interval (CI) = 1.33–1.46 vs mean
1.56, 95% CI = 1.44–1.67, P = .02) but a higher TIBI score
(mean 36.7, 95% CI = 17.7–55.6 vs mean 34.1, 95%
CI = 15.5–52.6, P = .009).
Time to death or right censoring ranged from 0.25 to
9.08 years. In 9 years (2002–11), 32.1% (n = 604) of
respondents died. Those with better care were more likely
to be alive at the end of the study period (January 1,
2011) (69.1% vs 64.3%, P = .05). Figure 1 shows the
unadjusted survival analysis curves for the two groups,
which were found to be statistically significantly different
according to the log rank test (P = .02). Before adjusting
for covariates, the group that received more recommended
care processes was less likely to die (hazard ratio (HR)
= 0.82, 95% CI = 0.69–0.98). For 14 of 1,879 respon-
dents (0.7%), one or more covariables were missing, so
the final multivariable analysis was performed on 1,865
respondents with complete information (Figure 2). After
inclusion of covariates that were significant in bivariate
analysis (in Model 5, which adjusted for age, sex, marital
status, net worth, education, physical function, geriatric
conditions, TIBI, and insulin use) respondents with more
care processes were even less likely to die (HR = 0.76,
95% CI = 0.64–0.91) (Table 2).
When the final multivariable model was stratified
according to age (≥ 75 vs <75), 57.2% of respondents in
the older group and 23.1% in the younger group had died.
The effect of being in the group receiving greater DM care
Table 2. Cox Proportional Hazard Model
Variable
Model 1,
n = 1,879
Model 2,
n = 1,879
Model 3,
n = 1,875
Model 4,
n = 1,873
Model 5,
n = 1,865
Hazard Ratio (95% Confidence Interval)
Process-of-care measuresa 0.82 (0.69–0.98)b 0.84 (0.70–0.997)b 0.87 (0.73–1.03) 0.84 (0.70–1.00)b 0.76 (0.64–0.91)b
Age
65–74 1.65 (1.31–2.07)b 1.61 (1.28–2.03)b 1.62 (1.29–2.04)b 1.70 (1.35–2.15)b
≥ 75 4.31 (3.47–5.35)b 4.10 (3.29–5.12)b 3.90 (3.12–4.87)b 4.53 (3.59–5.72)b
Female 0.73 (0.61–0.87)b 0.70 (0.60–0.84)b 0.69 (0.57–0.82)b
<High school education 1.19 (1.00–1.41)b 1.10 (0.93–1.31) 1.03 (0.86–1.23)
Single 1.28 (1.06–1.54)b 1.24 (1.03–1.50)b 1.26 (1.04–1.51)b
Net worth, $
<50,000 1.70 (1.24–2.33)b 1.43 (1.04–1.97)b 1.29 (0.93–1.78)
50,000–534,999 1.46 (1.09–1.96)b 1.42 (1.07–1.90)b 1.35 (1.00–1.80)b
≥1 activities of daily living 1.30 (1.07–1.58)b 1.14 (0.93–1.40)
≥1 instrumental activities of daily living 1.99 (1.63–2.43)b 1.82 (1.49–2.24)b
Geriatric conditions 1.01 (0.93–1.09)
Uses insulin 1.21 (1.00–1.46)b
Total Illness Burden Index 1.01 (1.01–1.02)b
Model 1: unadjusted.
Model 2: adjusted for age.
Model 3: adjusted for age, demographic characteristics, socioeconomic status (SES).
Model 4: adjusted for age, demographic characteristics, SES, functional health.
Model 5: adjusted for age, demographic characteristics, SES, functional health, comorbidities, insulin use.
a Glycosylated hemoglobin test, urine test, eye examination, aspirin counseling, and diabetes mellitus education (0 = 0–2, 1 = 3–5).
b P < .05.
Figure 1. Cox proportional hazards regression: unadjusted
survival probability of older adults with diabetes mellitus in
the sample.
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processes was stronger and more statistically significant in
the older group (HR = 0.72, 95% CI = 0.55–0.93) than in
the younger group (HR = 0.84, 95% CI = 0.65–1.09)
(Table 3). Sensitivity analyses using process-of-care mea-
sures as a continuous variable in the multivariable model
and different dichotomized care process groups (0–3 vs 4–
5 measures) gave comparable findings.
DISCUSSION
DM care process measures were developed to improve the
quality of DM care and to improve health outcomes.3 In
this nationally representative sample of middle-aged and
older Americans with DM, respondents who reported
receiving more of five selected DM care process measures
had significantly better survival over 9 years of follow-up
than those who received fewer. This association was inde-
pendent of age, sex, socioeconomic status, demographic
characteristics, functional health, geriatric conditions, insu-
lin use, and DM illness burden. More importantly, it was
demonstrated in a relatively small subsample of older
respondents aged 75 and older that basic, nonaggressive
care processes such as counseling and monitoring are not
harmful and seem to be associated with benefit.
These results focus on DM monitoring and counsel-
ing-type care processes, rather than achievement of inter-
mediate outcomes such as glycemic targets. The care
processes studied are distinct from those recommended to
achieve glycemic targets, such as prescribing hypoglycemic
and antihypertensive medications.7–10,20 Therefore, these
results do not contradict recent research suggesting that
aggressive glycemic and blood pressure control in older
adults appear to have diminishing marginal benefits than
more-modest targets and may even cause harm.21–23
These results should be viewed in light of prior research
on the long-term outcomes of care processes provided to
Model 1: Unadjusted (N=1,879) 
Model 4: Models 2&3 + 
Functional Health (N=1,873) 
4 participants excluded due to 
missing data (0.2%)
Respondents in 2002 HRS 
(N=18,167) 
Respondents ages ≥51 with 
both surveys (N=1,879) 
Respondents in 2003 Diabetes 
MailOut Survey (N=1,901)
Model 2: Age-Adjusted 
(N=1,879) 
Model 3: Model 2 + 
Demographic information + SES 
(N=1,875)
2 participants excluded due to 
missing data (0.1%)
Model 5: Models 2-4 + 
Comorbidities + Insulin use 
(N=1,865)
8 participants excluded due to 
missing data (0.4%)
Figure 2. : Flow of data from the Health and Retirement
Study (HRS) core interview: 2002 to final analytical sample.
SES = socioeconomic status.
Table 3. Cox Proportional Hazard Model Stratified According to Age
Variable
<75 ≥ 75
Model 1, n = 1,381 Model 5, n = 1,372 Model 1, n = 498 Model 5, n = 493
Hazard Ratio (95% Confidence Interval)
Process-of-care measuresa 0.88 (0.69–1.13) 0.84 (0.65–1.09) 0.82 (0.64–1.06)b 0.72 (0.55–0.93)b
Female 0.64 (0.51–0.82)b 0.69 (0.52–0.90)b
<High school education 1.14 (0.89–1.45) 0.98 (0.76–1.28)
Single 1.31 (1.01–1.70)b 1.27 (0.96–1.67)
Net worth, $
<50,000 1.10 (0.71–1.70) 1.31 (0.81–2.12)
50,000–534,999 1.11 (0.75–1.65) 1.50 (0.97–2.32)
≥1 activities of daily living 1.17 (0.87–1.57) 1.06 (0.79–1.41)
≥1 instrumental activities of daily living 1.63 (1.21–2.21)b 1.92 (1.45–2.54)b
Geriatric conditions 1.02 (0.91–1.13) 1.05 (0.95–1.17)
Uses insulin 1.19 (0.92–1.54) 1.16 (0.88–1.53)
Total Illness Burden Index 1.02 (1.01–1.02)b 1.01 (1.00–1.02)b
Model 1: unadjusted.
Model 5: adjusted for age, demographic characteristics, socioeconomic status, functional health, comorbidities.
aGlycosylated hemoglobin test, urine test, eye examination, aspirin counseling, and diabetes mellitus education (0 = 0–2, 1 = 3–5).
bP < .05.
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younger adults with DM. A systematic review24 examining
care processes for adults with DM, many on a practice sys-
tems level, found no association with hospitalizations, vas-
cular complications, or death. The authors concluded that
there is insufficient evidence that DM process measures, par-
ticularly those focused on tests performed, predict out-
comes.24 Two large observational studies based in Italy have
focused on composite scores of DM care. The first, a study
of more than 3,000 individuals from 101 DM clinics in
Italy, found no relationship between a comprehensive set of
care processes measured in medical record review and 5-
year survival.25 The second was a study of more than 5,000
patients in 62 clinics that found that better care processes
were associated with less risk of cardiovascular events over
a median follow-up of 28 months,26 although the results
were not statistically significant for survival.
In contrast, the current results found a relationship
with survival, possibly because of the older age of the sam-
ple, which would have resulted in greater mortality in gen-
eral, thereby affording better power for detecting
associations. One other study of older adults, the Assessing
the Care of Vulnerable Elders study, also reported that
composite care process measures (including but not limited
to DM care processes) measured using chart review in
older U.S. community-dwelling adults in primary care were
associated with short-term survival and better functional
status,27,28 independent of age at baseline.
The currently endorsed NQF comprehensive DM care
measures apply only until the age of 75,14 consistent with
the upper age limit of many clinical trials,29 but the
heterogeneity of older adults with DM and implications
for appropriateness of care has received increasing atten-
tion.9 Guidelines such as those that the American Geri-
atrics Society and the ADA endorse support customize
glycemic and blood pressure targets according to an older
individual’s functional status and life expectancy.2,9 The
current study findings suggest that this approach may also
feasibly be extended for DM care process measures. There
continued to be a survival benefit associated with monitor-
ing and counseling-type processes after age 75, possibly
because of greater mortality in general in older adults,
with age therefore resulting in greater power to detect a
benefit in older than in younger participants. Therefore,
for people aged 75 and older with functional independence
and a reasonable life expectancy, the current results sug-
gest that providing these types of less-burdensome care
processes may be appropriate.
This study has notable strengths. Because the HRS is
U.S. population based, rather than conducted in a particu-
lar healthcare setting or health insurance plan, the results
offer a perspective that prior studies could not. In addi-
tion, it was possible to control for aspects of illness that
many other studies cannot, including functional status,
two types of comorbidity (TIBI, count of geriatric condi-
tions), cognitive status, and socioeconomic status. Because
care processes are unlikely ever to be studied in a con-
trolled trial, population-based observational studies are
necessary, but most datasets do not include any of these
covariables. The opportunity to follow older adults longi-
tudinally for 9 years is also unique in this field.
Although a statistical association was found between
providing recommended care and survival, these results do
not suggest a mechanism. The relationship may be related to
unmeasured individual characteristics or behaviors or how
physicians provide care to specific individuals. It is possible
that less care is a marker for other prognostic factors, such
as poorer adherence to recommended care or poor access to
care, which are known to be associated with poor glycemic
and blood pressure control.30 Although these factors were
not directly measured in this study, adjustment for demo-
graphic characteristics and socioeconomic status should par-
tially account for these differences. Physicians may be
providing more care to people who appear healthier or more
functionally independent beyond what could be controlled
for with the data available. Alternatively, some individuals
with chronic disease receive more care presumably because
of more-frequent interactions with physicians,31 and the
current study data are consistent with this.
Common confounders of process and outcome,
namely income, education, the TIBI (a measure of comor-
bidity and symptoms), and functional status, were included
in the analyses. Such measures were previously found to
predict survival,32,33 although it is likely that clinical or
social complexity was undermeasured. There are further
unmeasured confounders that deserve future research. For
instance, the care process measures may have indirectly
accounted for individuals’ access to care, self-efficacy or
better self-care, and adherence to care, which may have
been the reason for longer survival. A previous study has
shown that the number of DM care processes may be asso-
ciated with satisfaction measures and self-rated quality of
DM care,20 which could in turn influence survival. Future
studies examining access to care, self-efficacy, self-care,
and adherence and their relationship with process mea-
sures and survival are needed.
This study has several other limitations. First, the
analysis was limited to adults who self-reported their diag-
nosis of DM and number of process-of-care measures
received. Problems with self-reported data include recall
bias and social-desirability bias. Although medical records,
which are considered to be a more accurate way to cap-
ture care processes, were not available, the study sheds
some light on self-perceived receipt of care. Interview is
considered to be a valid way to capture counseling-type
care processes.34 Second, the analysis included the five pro-
cess measures that were reliably available in the HRS data,
and did not include several important measures of DM
quality of care such as foot examinations, smoking cessa-
tion counseling, vaccinations, and blood pressure and lipid
targets.2,3,14 Furthermore, the HRS question for protein-
uria was worded simply to facilitate respondent compre-
hension as a “urine test,” thereby potentially introducing
misclassification if respondents recalled any other urine
test mistakenly for urine protein testing. It is unlikely that
this misclassification would have biased the results because
sicker individuals with need for other types of urine tests
would not be expected to have better survival. Third, over
the past 2 decades, process-of-care measures have evolved.
In 2003, when the HRS Mailout Survey was performed,
the recommendation from the ADA was to consider
aspirin therapy for primary cardiovascular prevention in
“high-risk adults” with DM, which included anyone aged
30 and older,15 but the ADA now recommends aspirin for
primary cardiovascular prevention for those with high car-
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diovascular risk profiles aside from age,2 and the American
Geriatrics Society has recommended caution because of
insufficient evidence supporting aspirin for primary cardio-
vascular prevention.9 Despite current uncertainty, in 2003,
aspirin counseling was recommended15 and therefore
reflects quality care as part of DM care processes at that
time. Fourth, the survey measured care processes delivered
at only one point in time (1 year before the mailout), so it
was presumed that the effect on survival did not vary with
time over the next 9 years. Quality of care may change,
for example, as a result of interventions designed to reduce
variation in care by targeting individuals receiving the
worst care, but it is likely that any such secular changes
would result in less variation in the predictor variable and
therefore bias the results toward finding no difference.
Finally, this study was not designed to study the associa-
tion between each individual care process and survival.
Composite scores, the combination of measures, have been
thought to be more reliable than single measures,6 but it is
possible that different methods of composite scores would
give different results. Nevertheless, sensitivity analyses
using different composite cut points of 0 to 3 versus 4 to 5
measures and using care processes as a continuous variable
resulted in similar findings. Nevertheless, the results should
not be interpreted as evidence in support of any particular
care process.
In conclusion, in a nationally representative sample,
individuals receiving better DM care as measured according
to receipt of care processes had better survival, and this
association was observable even in individuals aged 75 and
older. Current care process measures end eligibility at age
75, but this study suggests that further research is needed to
consider whether some older adults with reasonable life
expectancies should continue to receive certain care process
measures. The current findings suggest that age alone
should not exclude older adults with DM from having their
quality of DM counseling and monitoring assessed.
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